Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

House Approves Medicare Regulatory Relief, Senate Will Address Bill In 2002

This article was originally published in The Gray Sheet

Executive Summary

AdvaMed is hoping that the final draft of Medicare regulatory relief legislation will include a provision authorizing the council for technology and innovation within the Centers for Medicare & Medicaid Services to be led by a political appointee

You may also be interested in...



Coverage Time Lag Can Be Solved By Gathering Data Early On, Gustafson Says

The House Energy & Commerce Committee is pressing for passage of a Medicare regulatory relief bill in the Senate in order to expedite its likely inclusion in a larger Medicare reform package later this year

Coverage Time Lag Can Be Solved By Gathering Data Early On, Gustafson Says

The House Energy & Commerce Committee is pressing for passage of a Medicare regulatory relief bill in the Senate in order to expedite its likely inclusion in a larger Medicare reform package later this year

House Leadership To Senate: Medicare Relief Legislation Should Pass In 2001

House Energy & Commerce and Ways & Means Committee leaders are accelerating last-ditch efforts to sign into law this year Medicare regulatory and contracting reform legislation (HR 3391), most recently with a Dec. 12 "Dear Colleague" letter intended to spur the Senate into action

Latest Headlines
See All
UsernamePublicRestriction

Register

MT015814

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel